Literature DB >> 25271610

Exemestane with ovarian suppression in premenopausal breast cancer.

Olivia Pagani, Meredith M Regan, Prudence A Francis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25271610     DOI： 10.1056/NEJMc1409366

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

Review 1.  Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019).

Authors:  Diana Lüftner; Ingo Bauerfeind; Michael Braun; Sara Y Brucker; Peter A Fasching; Ricardo Felberbaum; Friederike Hagemann; Renate Haidinger; Nadia Harbeck; Arnd Hönig; Jens Huober; Christian Jackisch; Hans-Christian Kolberg; Cornelia Kolberg-Liedtke; Thorsten Kühn; Nicolai Maass; Toralf Reimer; Andreas Schneeweiss; Eva Schumacher-Wulf; Florian Schütz; Christoph Thomssen; Michael Untch; Rachel Wuerstlein; Marc Thill
Journal:  Breast Care (Basel)       Date:  2019-09-17       Impact factor: 2.860

2.  Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017).

Authors:  Michael Untch; Jens Huober; Christian Jackisch; Andreas Schneeweiss; Sara Y Brucker; Peter Dall; Carsten Denkert; Peter A Fasching; Tanja Fehm; Bernd Gerber; Wolfgang Janni; Thorsten Kühn; Diana Lüftner; Volker Möbus; Volkmar Müller; Achim Rody; Peter Sinn; Marc Thill; Christoph Thomssen; Nadia Harbeck; Cornelia Liedtke
Journal:  Geburtshilfe Frauenheilkd       Date:  2017-06-28       Impact factor: 2.915

Review 3.  Progress in adjuvant chemotherapy for breast cancer: an overview.

Authors:  Jesus Anampa; Della Makower; Joseph A Sparano
Journal:  BMC Med       Date:  2015-08-17       Impact factor: 8.775

4.  Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.

Authors:  Raquel E Reinbolt; Stephen Sonis; Cynthia D Timmers; Juan Luis Fernández-Martínez; Ana Cernea; Enrique J de Andrés-Galiana; Sepehr Hashemi; Karin Miller; Robert Pilarski; Maryam B Lustberg
Journal:  Cancer Med       Date:  2017-11-23       Impact factor: 4.452

5.  In silico analysis identified miRNA‑based therapeutic agents against glioblastoma multiforme.

Authors:  Dan-Dan Xiong; Wen-Qing Xu; Rong-Quan He; Yi-Wu Dang; Gang Chen; Dian-Zhong Luo
Journal:  Oncol Rep       Date:  2019-02-19       Impact factor: 3.906
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.